Global Skin Antiseptic Products Market Size

Skin Antiseptic Products Market Analysis

The skin antiseptic products market is projected to register a CAGR of 7.5% during the forecast period.

The healthcare system has witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. However, with the advent of the COVID-19 infection, the necessity for antiseptic products has increased significantly, to restrict the spread of the infection. For instance, an article titled 'Oral Antiseptics Against Coronavirus: In-Vitro and Clinical Evidence' published in the Journal of Hospital Infection in July 2021 indicated that oral antiseptics can be used in the inactivating and eradicating the coronaviruses, thereby leading to a lower risk of transmission via salivary droplets or aerosols. The article suggested the use of oral antiseptics such as povidone-iodine, hydrogen peroxide, chlorhexidine, and cetylpyridinium chloride to reduce the intra-oral viral load in COVID-19-positive patients. The increasing use of antiseptics during the COVID-19 pandemic significantly added to the market growth.

The demand for these products is increasing, due to a higher prevalence of Hospital Acquired Infections (HAIs), lack of sanitation and precaution, and increased use of surgical units and endoscope reprocesses. Furthermore, the global antiseptic industry is witnessing a higher rate of growth, due to increased expenditure on healthcare, elevated incidences of hospital-acquired infectious diseases, and increased awareness of cleanliness and disinfection measures. Skin antiseptic is used to maintain human or non-living germ-free. With COVID-19, there has been an increase in awareness about bacterial, viral, and fungal infections and their prevention with the use of antiseptics. This is expected to have a positive impact on the market growth.

Also, the increase in nosocomial infections poses a serious challenge to health care professionals globally during the COVID-19 pandemic. In September 2021, a study published in the Infection Control and Hospital Epidemiology titled "The Impact of Coronavirus Disease 2019 (COVID-19) on Healthcare-Associated Infections in 2020: A Summary of Data Reported to The National Healthcare Safety Network" showed that there was a significant increase in the number of healthcare-associated infections (HAIs) in the year 2020 than the previous year. The rapid rise in HAIs is majorly attributed to the COVID-19 pandemic. Hospitals are found to boost their infection control protocols to avoid or destroy hospital-acquired infections for the patient and hospital staff's safety. Thus, there is an increasing demand for the skin antiseptics market to prevent the further spread of such hospital-acquired infections. These infections also present a significant economic burden at the societal level. However, a large percentage of HAIs are preventable through effective infection prevention and control measures. Thus, the increasing demand for the prevention of hospital-acquired infections is likely to add to the growth of the studied market during the forecast period.

Moreover, the recent antiseptic product launches by market players worldwide are adding to the market growth. For instance, in November 2021, Emami Limited launched the non-sticky antiseptic cream BoroPlus soft ayurvedic antiseptic cream in India. Also, in December 2021, MedLife Formulations Pvt. Ltd. launched Septicol antiseptic liquid, which is effective in killing or slowing down viruses, bacteria, and other harmful microorganisms. Such product launches are expected to significantly add to the growth of the studied market during the forecast period.

However, the side effects associated with the antiseptics and the risk of permeability are hindering the growth of the skin antiseptics market.